2000
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1074/jbc.M909721199
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/10748154
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/0021-9258
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_15C09F6E6B8D4
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
J.L. Bodmer et al., « Cysteine 230 is essential for the structure and activity of the cytotoxic ligand TRAIL. », Serveur académique Lausannois, ID : 10.1074/jbc.M909721199
Unlike other tumor necrosis factor family members, the cytotoxic ligand tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo-2L contains an unpaired cysteine residue (Cys(230)) in its receptor-binding domain. Here we show that the biological activity of both soluble recombinant TRAIL and cell-associated, full-length TRAIL is critically dependent on the presence of Cys(230). Mutation of Cys(230) to alanine or serine strongly affected its ability to kill target cells. Binding to its receptors was decreased by at least 200-fold, and the stability of its trimeric structure was reduced. In recombinant TRAIL, Cys(230) was found engaged either in interchain disulfide bridge formation, resulting in poorly active TRAIL, or in the chelation of one zinc atom per TRAIL trimer in the active, pro-apoptotic form of TRAIL.